Table 2

Incidence and hierarchy of complications seen during long term follow up in cirrhotic patients according to aetiology

HCV+/HBsAg− (n = 254)HCV−/HBsAg+ (n = 43)HCV+/HBsAg+ (n = 15)
Overall incidence
    At least one complication78 (30.7%)15 (34.8%)8 (53.3%)
    HCC52 (20.5%)6 (13.9%)7 (46.7%)
    Ascites45 (17.7%)10 (23.2%)6 (40.0%)
    Bleeding12 (4.7%)1 (2.3%)0
    Encephalopathy5 (1.9%)1 (2.3%)0
    Progression of Child stage46 (18.1%)9 (20.9%)7 (46.7%)
    Liver related death42 (16.3%)9 (20.9%)7 (46.7%)
Hierarchy
    First event occurring
        HCC47 (18.5%)6 (13.9%)6 (40.0%)
        Ascites24 (9.4%)8 (18.6%)2 (13.3%)
        Bleeding5 (1.9%)0 (0%)0 (0%)
        Encephalopathy2 (0.8%)1 (2.3%)0 (0%)